Corvus to boost precision manufacture with MMI funds

Melbourne-based Corvus Technology Solutions will install high precision machinery at its’ defence manufacturing facility in Victoria, utilising recently announced funding in the first round of the federal government’s Modern Manufacturing Initiative (MMI). This will enable Corvus to produce a large number of precision parts and tooling with very high accuracy and consistency for the defence,…

Details

IT consulting specialist SOCO helps Australian manufacturers charge into the future with modern ERP solutions

ADVERTISING FEATURE SOCO will be hosting the event “Charging into the Future: Modern ERP for Manufacturers” on Wednesday, 8 March 2023 at the Microsoft Melbourne office. This intimate event is purposefully designed to help manufacturing executives and leaders explore the technology trends influencing the development of contemporary ERP software. Attendees will learn about how new…

Details

Best of the week — the five most popular stories among @AuManufacturing’s readers

What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) $10.2 MILLION IN ARC LINKAGE GRANTS ANNOUNCED FOR ADVANCED MANUFACTURING PROJECTS Advanced manufacturing had a high representation among the latest round of projects supported through the Australian Research Council Linkage program. Funds totalling $40 million for 81…

Details

Orbital broadens customer base, boosts revenue

Unmanned aerial vehicle (UAV) engine manufacturer Orbital Corporation has announced a revenue boost from efforts to broaden its customer base. Orbital reported today first half revenue of $14.1 million, up from $11.2 million in the previous corresponding period. The Perth company, once focused a single customer, Boeing’s In situ division, is now building engines or…

Details

Manufacturing news briefs — stories you might have missed

Arovella, Imugene progress drug combination trials ASX-listed companies Arovella Therapeutics and Imugene have announced a successful outcome from the initial in vitro experiments conducted as part of their research collaboration, and are progressing to the next phase of testing. According to a statement on Friday, results show that the combination of Arovella’s CAR19-iNKT cell therapy…

Details